Antibody Validation

Cell lines
Six human lung, prostate and breast cancer cell lines A549 (CCL-185), NCI-H460 (HTB-177), DU145 (HTB-81), PC3 (CRL-1435), MCF7(HTB-22) and MDA-MB-231(HTB-26), all from ATCC (Manassas, VA), were cultured in RPMI 1640 media (R8758, Sigma-Aldrich).
All media were supplemented with 10% fetal bovine serum (S0415, Biochrom) and 1× penicillin-streptomycin antibiotic mixture (P0781, Sigma-Aldrich). Cells were incubated at 37°C in a humidified atmosphere with 5% CO 2 . STR-profiling was performed to verify the cell lines authenticity by the department of Forensic Medicine at UiT The Arctic University of Norway.
Western Blot analysis
Cells were washed in ice-cold phosphate-buffered saline, and lysate was added directly in NuPAGE LDS Sample Buffer (NP0007, Life Technologies) with dithiothreitol. In addition, HEK 293 cell lysates were utilized beside from OriGene for ERα (LY400046), ERβ1 (LY425704) and aromatase (LY400031) and were incubated with 2xSDS Sample Buffer (OriGene) for 10 minutes at 100°C. Equal amounts of protein lysates were resolved onto a 4% to 12% Bis-Tris gel (NP0322; Life Technologies). The resolved proteins were transferred onto an Odyssey nitrocellulose membrane (926-31092, LI-COR), and the membrane was subsequently blocked for 1 hour at room temperature using the Odyssey blocking buffer (927-40000, LI-COR ). For all three Primary antibodies 1/500 dilution applied and the membrane incubated for over night at 4˚C. The following IRDye 800CW secondary antibodies for ERα (926-32213, LI-COR),ERβ1 (926-32212, L1-COR) and aromatase (935-32214,L1-COR) with 1/10000 dilution incubated 1 hour at RT. Rabbit anti-actin, 1:1000 (A2066, Sigma-Aldrich) was used as internal control and all lanes shows 42 KDa molecular weight protein load.
Between antibody incubations, the membrane was washed three times for 5 minutes each time in tris-buffered saline containing 0.05 % Tween 20 (Sigma-Aldrich). Molecular weight markers used were the MagicMark XP Western Protein Standard (LC5603, Invitrogen) and SeeBlue Plus2 Pre-stained Standard (LC5925, Invitrogen).
Antibody validation results
Western blot analysis was used to verify the specificity of the primary antibodies ( Figure S1 , Table S1 ). The observed molecular weight of the detected protein (the most prominent bands) in lung, prostate and breast cell line lysates corresponded intimately with the predicted weight, as with the data provided by the manufacturers. Transiently overexpressed lysate of each primary antibody and empty vector was applied in order to further accredit specificity.
Minor variations of molecular weight band location can be explained by specific conditions during sample preparation and post-translational modification. This includes glycosylation and phosphorylation, which can result in an increase in molecular weight.
Supplementary figure 1
Western blot analysis verifying the specificity of the primary antibodies (A, C, E) using rabbit actin as internal control (B, D, F): A-B) ERα, C-D) ERβ and E-F) aromatase. Six human cancer cell liens including lung (A549, NCI-H460), prostate (DU145, PC3) and breast cancer (MCF7 and MDA-MB-231), corresponding over-expressed domain protein lysates (HEK293T) and negative control of over-expressed lysates (HEK293) were applied. The most prominent bands represent the observed molecular weight of the detected protein, which corresponded intimately with the predicted weight provided by the manufacturer. 
Supplementary table 1
